JPWO2023133568A5 - - Google Patents

Info

Publication number
JPWO2023133568A5
JPWO2023133568A5 JP2024541154A JP2024541154A JPWO2023133568A5 JP WO2023133568 A5 JPWO2023133568 A5 JP WO2023133568A5 JP 2024541154 A JP2024541154 A JP 2024541154A JP 2024541154 A JP2024541154 A JP 2024541154A JP WO2023133568 A5 JPWO2023133568 A5 JP WO2023133568A5
Authority
JP
Japan
Prior art keywords
modified
cells
present
molecules
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504392A5 (https=
JP2025504392A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060341 external-priority patent/WO2023133568A2/en
Publication of JP2025504392A publication Critical patent/JP2025504392A/ja
Publication of JP2025504392A5 publication Critical patent/JP2025504392A5/ja
Publication of JPWO2023133568A5 publication Critical patent/JPWO2023133568A5/ja
Pending legal-status Critical Current

Links

JP2024541154A 2022-01-10 2023-01-09 多能性幹細胞から分化した低免疫性β細胞ならびに関連する使用及び方法 Pending JP2025504392A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202263298214P 2022-01-10 2022-01-10
US63/298,214 2022-01-10
US202263320691P 2022-03-16 2022-03-16
US63/320,691 2022-03-16
US202263322208P 2022-03-21 2022-03-21
US63/322,208 2022-03-21
US202263352605P 2022-06-15 2022-06-15
US63/352,605 2022-06-15
US202263353534P 2022-06-17 2022-06-17
US63/353,534 2022-06-17
PCT/US2023/060341 WO2023133568A2 (en) 2022-01-10 2023-01-09 Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods

Publications (3)

Publication Number Publication Date
JP2025504392A JP2025504392A (ja) 2025-02-12
JP2025504392A5 JP2025504392A5 (https=) 2026-01-19
JPWO2023133568A5 true JPWO2023133568A5 (https=) 2026-01-19

Family

ID=87074351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541154A Pending JP2025504392A (ja) 2022-01-10 2023-01-09 多能性幹細胞から分化した低免疫性β細胞ならびに関連する使用及び方法

Country Status (9)

Country Link
US (1) US20250223564A1 (https=)
EP (1) EP4463171A4 (https=)
JP (1) JP2025504392A (https=)
KR (1) KR20240142624A (https=)
AU (1) AU2023204829A1 (https=)
CA (1) CA3246902A1 (https=)
IL (1) IL314029A (https=)
MX (1) MX2024008571A (https=)
WO (1) WO2023133568A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024229302A1 (en) * 2023-05-03 2024-11-07 Sana Biotechnology, Inc. Methods of dosing and administration of engineered islet cells
IL325954A (en) * 2023-07-28 2026-03-01 Vertex Pharma Cell therapy for diabetes
CN116732099B (zh) * 2023-08-07 2023-11-24 北赛泓升(北京)生物科技有限公司 一种干细胞多重CRISPR/Cas基因组编辑方法
WO2025117331A1 (en) 2023-12-01 2025-06-05 Eli Lilly And Company Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same
WO2025212859A1 (en) * 2024-04-03 2025-10-09 Solid Biosciences, Inc. Methods and constructs for increasing solid organ transplant survival

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE057135T2 (hu) * 2015-09-01 2022-04-28 Ncardia B V In vitro módszer egy humán pluripotens õssejtpopuláció kardiomiocita sejtpopulációvá történõ differenciálására
CN110177869A (zh) * 2017-01-13 2019-08-27 加利福尼亚大学董事会 免疫改造的多能细胞
US20210308183A1 (en) * 2018-07-17 2021-10-07 The Regents Of The University Of California Chimeric antigen receptor t cells derived from immunoengineered pluripotent stem cells
BR112021000637A2 (pt) * 2018-07-17 2021-04-13 The Regents Of The University Of California Célula cardíaca hipoimune isolada, método para tratar um paciente que sofre de uma afecção ou doença cardíaca, método para produzir uma população de células cardíacas hipoimunes, célula endotelial hipoimune isolada, método para tratar um paciente que sofre de uma afecção ou doença vascular, método para produzir uma população de células endoteliais hipoimunes, neurônio dopaminérgico hipoimune isolado, método para tratar um paciente que sofre de uma doença ou afecção neurodegenerativa, método para produzir uma população de neurônios dopaminérgicos hipoimunes, célula de ilhota pancreática hipoimune isolada, método para tratar um paciente que sofre de diabetes, método para produzir uma população de células de ilhota pancreática hipoimunes, célula de epitélio pigmentado da retina (rpe) hipoimune isolada, método para tratar um paciente que sofre de uma afecção ocular, e método para produzir uma população de células de epitélio pigmentado da retina (rpe) hipoimunes
CN115916962A (zh) * 2020-04-27 2023-04-04 萨那生物技术股份有限公司 低免疫原性细胞的重复给药

Similar Documents

Publication Publication Date Title
JP7348160B2 (ja) ヌクレアーゼ媒介ゲノム遺伝子操作のための送達方法及び組成物
JP7753197B2 (ja) ユニバーサルドナー細胞
JP2021518160A (ja) 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法
JP2022547053A (ja) ユニバーサルドナー細胞
TW202202155A (zh) 用於治療神經病症及病況之低免疫原性神經細胞
JP7642548B2 (ja) 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法
US20210213062A1 (en) Drug-Resistant Immune Cells and Methods of Use Thereof
US20250223564A1 (en) Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods
JP2024503290A (ja) ユニバーサルドナー細胞
JP2024512608A (ja) Tリンパ球における効率的なtcr遺伝子編集
JP2024177252A (ja) カルボジイミドで処理された寛容化ワクチンによる移植寛容誘導
JP2021500080A (ja) 高IgM症候群を処置するためのシステム及び方法
US20240132843A1 (en) Methods for expanding regulatory t cells
IL319487A (en) Immune cells having co-expressed tgfbr shrnas
JPWO2023133568A5 (https=)
US20250027930A1 (en) Small molecules for reprograming anti-tumor immunity of t cells
KR102906951B1 (ko) 내인성 항원 제시 기전을 이용한 저면역원성 줄기세포 및 이의 제조 방법
US20250222103A1 (en) Immune cells with combination gene perturbations
Ju et al. Generation of hypoimmunogenic universal iPSCs through HLA-type gene knockout
KR102616080B1 (ko) 알츠하이머 예방 또는 치료용 약학적 조성물 및 이의 용도